Revolutionary Gold Treatment Shows Promise in Reversing Parkinson’s and Multiple Sclerosis Symptoms
Researchers at the University of Texas Southwestern Medical Center have made an exciting breakthrough in the treatment of multiple sclerosis (MS) and Parkinson’s disease. In a phase two clinical trial, they successfully used suspended nanocrystals of gold as a potential therapy for these debilitating conditions.
The gold nanocrystals work by targeting and altering the brain’s energy balance, which is often disrupted in MS and Parkinson’s. This disruption is believed to contribute to the neurological disabilities associated with these diseases.
The study involved 11 patients with relapsing MS and 13 patients with Parkinson’s. Each participant received a daily dose of gold nanocrystals for 12 weeks. The results were promising.
Participants with Parkinson’s experienced an average increase of 10.4% in essential markers for energy metabolism. They also reported improved motor function, which is a significant improvement for individuals with this disease. Importantly, no adverse side effects were reported during the study.
The researchers are cautiously optimistic that this treatment could potentially prevent or even reverse some neurological disabilities associated with MS and Parkinson’s. These findings offer hope for the millions of Americans who suffer from these conditions, as it could slow down the decline in brain function and improve symptoms.
It’s important to note that the study was funded by Clene Nanomedicine, a company that is developing the gold nanocrystals as a therapeutic agent for neurodegenerative conditions. Their support demonstrates confidence in the potential of this treatment.
The researchers now hope to see similar positive results in the trial participants with MS. If successful, this could open up new avenues for the development of more effective treatments for MS, Parkinson’s, and other neurological conditions.
Overall, this study represents a significant advancement in the search for solutions to MS and Parkinson’s. The use of gold nanocrystals to improve brain energy metabolism shows promise and could have far-reaching implications for the field of neurology.